- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 189-203 of
276 results
1059 Exhibit: Exhibit 1059 Santen Pharmaceutical Co, Ltd Data Book 2017
Document
IPR2017-01434, No. 1059 Exhibit - Exhibit 1059 Santen Pharmaceutical Co, Ltd Data Book 2017 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
2051 Exhibit: Ex 2051 WestLaw Version of Alcon Canada v Apotex
Document
IPR2017-01434, No. 2051 Exhibit - Ex 2051 WestLaw Version of Alcon Canada v Apotex (P.T.A.B. Aug. 9, 2018)
|
|
Cite Document
1043 Exhibit: Fogagnolo, Paolo et al ¿¿¿A 1 Year Randomized Study of the Clinical a...
Document
IPR2017-01434, No. 1043 Exhibit - Fogagnolo, Paolo et al ¿¿¿A 1 Year Randomized Study of the Clinical and Confocal Effects of Tafluprost and Latanoprost in Newly Diagnosed Glaucoma Patient...
|
|
Cite Document
1050 Exhibit: Judith AK Howard et al, ¿¿¿How Good is Fluorine as aHydrogen Bond A...
Document
IPR2017-01434, No. 1050 Exhibit - Judith AK Howard et al, ¿¿¿How Good is Fluorine as aHydrogen Bond Acceptor¿¿¿ Tetrahedron, 5212613¿¿¿12622 Sept 1996 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
1063 Exhibit: Exhibit 1063 Kubinyi1979 Progress in Drug research 23 97 1979
Document
IPR2017-01434, No. 1063 Exhibit - Exhibit 1063 Kubinyi1979 Progress in Drug research 23 97 1979 (P.T.A.B. Aug. 9, 2018)
|
|
Cite Document
1049 Exhibit: Bito LZ, ¿¿¿Comparison of the Ocular Hypotensive Efficacy of Eicosan...
Document
IPR2017-01434, No. 1049 Exhibit - Bito LZ, ¿¿¿Comparison of the Ocular Hypotensive Efficacy of Eicosanoids and Related Compounds,¿¿¿ Exp Eye Res, 382181¿¿¿94 1984 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
2053 Exhibit: Ex 2053 Tafluprost PMDA Entry
Document
IPR2017-01434, No. 2053 Exhibit - Ex 2053 Tafluprost PMDA Entry (P.T.A.B. Aug. 9, 2018)
|
|
Cite Document
1057 Exhibit: Exhibit 1057 Aerie Pharmaceuticals, Inc Form 8 K 2017
Document
IPR2017-01434, No. 1057 Exhibit - Exhibit 1057 Aerie Pharmaceuticals, Inc Form 8 K 2017 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
2029 Exhibit: Ex2029 Supplemental Fechtner Declaration
Document
IPR2017-01434, No. 2029 Exhibit - Ex2029 Supplemental Fechtner Declaration (P.T.A.B. Mar. 5, 2018)
|
|
Cite Document
1055 Exhibit: Exhibit 1055 GlobalData Healthcare 2018
Document
IPR2017-01434, No. 1055 Exhibit - Exhibit 1055 GlobalData Healthcare 2018 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
2056 Exhibit: Ex 2056 Human Metabolome Database tafluprost
Document
IPR2017-01434, No. 2056 Exhibit - Ex 2056 Human Metabolome Database tafluprost (P.T.A.B. Jul. 26, 2018)
|
|
Cite Document
1047 Exhibit: Resul B et al, ¿¿¿Phenyl Substituted Prostaglandins Potent and Select...
Document
IPR2017-01434, No. 1047 Exhibit - Resul B et al, ¿¿¿Phenyl Substituted Prostaglandins Potent and Selective Antiglaucoma Agents,¿¿¿ J Med Chem, 36243¿¿¿248 1993 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
1037 Exhibit: Alan Robin, MD, ¿¿¿Two new options will make glaucoma therapy safer...
Document
IPR2017-01434, No. 1037 Exhibit - Alan Robin, MD, ¿¿¿Two new options will make glaucoma therapy safer,¿¿¿ Primary Care Optometry News, July 1996 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
1065 Exhibit: Petitioners Demonstrative Exhibits Oral Argument
Document
IPR2017-01434, No. 1065 Exhibit - Petitioners Demonstrative Exhibits Oral Argument (P.T.A.B. Aug. 31, 2018)
|
|
Cite Document
1058 Exhibit: Santen Pharmaceutical Co, Ltd Data Book 2015
Document
IPR2017-01434, No. 1058 Exhibit - Santen Pharmaceutical Co, Ltd Data Book 2015 (P.T.A.B. Jun. 5, 2018)
|
|
Cite Document
